Apoptotic Threshold is Lowered by P53 Transactivation of Caspase-6

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2002 Jun 29

PMID 12089322

Citations 56

Authors

Timothy K MacLachlan

Wafik S El-Deiry

Affiliations

Soon will be listed here.

Abstract

Little is known about how a cell's apoptotic threshold is controlled after exposure to chemotherapy, although the p53 tumor suppressor has been implicated. We identified executioner caspase-6 as a transcriptional target of p53. The mechanism involves DNA binding by p53 to the third intron of the caspase-6 gene and transactivation. A p53-dependent increase in procaspase-6 protein level allows for an increase in caspase-6 activity and caspase-6-specific Lamin A cleavage in response to Adriamycin exposure. Specific inhibition of caspase-6 blocks cell death in a manner that correlates with caspase-6 mRNA induction by p53 and enhances long-term survival in response to a p53-mediated apoptotic signal. Caspase-6 is an executioner caspase found directly regulated by p53, and the most downstream component of the death pathway controlled by p53. The induction of caspase-6 expression lowers the cell death threshold in response to apoptotic signals that activate caspase-6. Our results provide a potential mechanism of lowering the death threshold, which could be important for chemosensitization.

Citing Articles

Interpretable identification of cancer genes across biological networks via transformer-powered graph representation learning.

Su X, Hu P, Li D, Zhao B, Niu Z, Herget T Nat Biomed Eng. 2025; .

PMID: 39789329 DOI: 10.1038/s41551-024-01312-5.

Static Magnetic Stimulation and Magnetic Microwires Synergistically Enhance and Guide Neurite Outgrowth.

Neuman K, Zhang X, Lejeune B, Pizzarella D, Vazquez M, Lewis L Adv Healthc Mater. 2024; 14(3):e2403956.

PMID: 39568232 PMC: 11773108. DOI: 10.1002/adhm.202403956.

Strong activation of p53 by actinomycin D and nutlin-3a overcomes the resistance of cancer cells to the pro-apoptotic activity of the FAS ligand.

Lasut-Szyszka B, Gdowicz-Klosok A, Krzesniak M, Glowala-Kosinska M, Bedzinska A, Rusin M Apoptosis. 2024; 29(9-10):1515-1528.

PMID: 39068622 PMC: 11416401. DOI: 10.1007/s10495-024-02000-0.

Design and mathematical analysis of activating transcriptional amplifiers that enable modular temporal control in synthetic juxtacrine circuits.

Lam C Synth Syst Biotechnol. 2023; 8(4):654-672.

PMID: 37868744 PMC: 10587772. DOI: 10.1016/j.synbio.2023.09.008.

Interlukin-4 weakens resistance to stress injury and megakaryocytic differentiation of hematopoietic stem cells by inhibiting Psmd13 expression.

Gao A, Xu S, Li Q, Zhu C, Wang F, Wang Y Sci Rep. 2023; 13(1):14253.

PMID: 37653079 PMC: 10471741. DOI: 10.1038/s41598-023-41479-6.

References

Gupta S, Radha V, Furukawa Y, Swarup G . Direct transcriptional activation of human caspase-1 by tumor suppressor p53. J Biol Chem. 2001; 276(14):10585-8. DOI: 10.1074/jbc.C100025200. View

Soengas M, Capodieci P, Polsky D, Mora J, Esteller M, McCombie R . Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature. 2001; 409(6817):207-11. DOI: 10.1038/35051606. View

Galande S, Dickinson L, Mian I, Sikorska M, Kohwi-Shigematsu T . SATB1 cleavage by caspase 6 disrupts PDZ domain-mediated dimerization, causing detachment from chromatin early in T-cell apoptosis. Mol Cell Biol. 2001; 21(16):5591-604. PMC: 87280. DOI: 10.1128/MCB.21.16.5591-5604.2001. View

Komata T, Kondo Y, Kanzawa T, Hirohata S, Koga S, Sumiyoshi H . Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (human telomerase reverse transcriptase) gene promoter. Cancer Res. 2001; 61(15):5796-802. View

Yu J, Zhang L, Hwang P, Kinzler K, Vogelstein B . PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell. 2001; 7(3):673-82. DOI: 10.1016/s1097-2765(01)00213-1. View

Nakano K, Vousden K . PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell. 2001; 7(3):683-94. DOI: 10.1016/s1097-2765(01)00214-3. View

Stambolic V, Macpherson D, Sas D, Lin Y, Snow B, Jang Y . Regulation of PTEN transcription by p53. Mol Cell. 2001; 8(2):317-25. DOI: 10.1016/s1097-2765(01)00323-9. View

Shivapurkar N, Maitra A, Milchgrub S, Gazdar A . Deletions of chromosome 4 occur early during the pathogenesis of colorectal carcinoma. Hum Pathol. 2001; 32(2):169-77. DOI: 10.1053/hupa.2001.21560. View

Robles A, Bemmels N, Foraker A, Harris C . APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis. Cancer Res. 2001; 61(18):6660-4. View

10.

Lowe S, Ruley H, Jacks T, Housman D . p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 1993; 74(6):957-67. DOI: 10.1016/0092-8674(93)90719-7. View

11.

El-Deiry W, Tokino T, Velculescu V, Levy D, Parsons R, Trent J . WAF1, a potential mediator of p53 tumor suppression. Cell. 1993; 75(4):817-25. DOI: 10.1016/0092-8674(93)90500-p. View

12.

Lowe S, Bodis S, McClatchey A, Remington L, Ruley H, Fisher D . p53 status and the efficacy of cancer therapy in vivo. Science. 1994; 266(5186):807-10. DOI: 10.1126/science.7973635. View

13.

Alnemri E, Livingston D, Nicholson D, Salvesen G, Thornberry N, Wong W . Human ICE/CED-3 protease nomenclature. Cell. 1996; 87(2):171. DOI: 10.1016/s0092-8674(00)81334-3. View

14.

Macleod K, Hu Y, Jacks T . Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J. 1996; 15(22):6178-88. PMC: 452439. View

15.

Rao L, Perez D, White E . Lamin proteolysis facilitates nuclear events during apoptosis. J Cell Biol. 1996; 135(6 Pt 1):1441-55. PMC: 2133948. DOI: 10.1083/jcb.135.6.1441. View

16.

Tan X, Martin S, Green D, Wang J . Degradation of retinoblastoma protein in tumor necrosis factor- and CD95-induced cell death. J Biol Chem. 1997; 272(15):9613-6. DOI: 10.1074/jbc.272.15.9613. View

17.

Porter A, Ng P, Janicke R . Death substrates come alive. Bioessays. 1997; 19(6):501-7. DOI: 10.1002/bies.950190609. View

18.

Thornberry N, Rano T, Peterson E, Rasper D, Timkey T, Garcia-Calvo M . A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem. 1997; 272(29):17907-11. DOI: 10.1074/jbc.272.29.17907. View

19.

Nicholson D, Thornberry N . Caspases: killer proteases. Trends Biochem Sci. 1997; 22(8):299-306. DOI: 10.1016/s0968-0004(97)01085-2. View

20.

Thornberry N . The caspase family of cysteine proteases. Br Med Bull. 1997; 53(3):478-90. DOI: 10.1093/oxfordjournals.bmb.a011625. View